查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1712512

全球可互通医疗资讯科技（健康IT）系统市场－2025-2033

Global Interoperable Healthcare Information Technology (Health IT) Systems Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 165 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球可互通医疗资讯科技 (Health IT) 系统市场规模达到 30.8 亿美元，预计到 2033 年将达到 231.8 亿美元，在 2025-2033 年预测期内的复合年增长率为 22.3%。

可互通的医疗保健资讯技术 (Health IT) 系统是促进不同提供者、机构和 IT 系统之间安全、无缝和标准化地交换医疗保健资料的数位平台。这些系统实现了 EHR、实验室系统、影像系统和药房系统等各种技术的有效协作。医疗保健领域互通性的主要目标是透过提供准确、最新的医疗资讯来改善病患照护。可互操作系统支援更好的协调，减少测试重复，增强决策能力，并透过整个医疗保健生态系统的有效沟通和协作改善医疗保健结果。执行摘要

市场动态：

驾驶员和约束装置

无缝患者资料交换需求日益增长

可互通医疗 IT 系统市场受到跨医疗环境无缝患者资料交换需求的驱动，从而实现更快、更协调的护理。这些解决方案改善了临床决策并减少了医疗错误。政府的授权和激励措施，特别是在北美和欧洲等已开发市场，支持推动互联医疗系统的发展。

随着对这些解决方案的需求不断增长，该公司正在推出先进的医疗保健 IT 解决方案。例如，2025 年 3 月，eHealth Technologies 在 FHIR 上推出了 eHealth Connect，这是一种与领先的 EHR 提供者整合的医疗保健技术解决方案。这种整合基于行业标准快速医疗互通性资源 (FHIR)，可实现医疗系统之间安全、即时的资料交换。 eHealth Connect平台为两个平台之间的医疗记录检索提供了无缝连接。

实施和整合成本高

实施可互通的医疗保健 IT 系统的高成本对于中小型医疗保健提供者来说是一个重大障碍，因为他们面临系统升级、基础设施变更和员工培训的前期投资。将遗留系统与现代平台整合的复杂性也会限制其广泛采用，尤其是在新兴市场。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第二章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按类型分类的程式码片段
  • 按互通性等级分類的程式码片段
  • 以部署方法分类的程式码片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第三章：动态

  • 影响因素
    • 驱动程式
      • 无缝患者资料交换需求日益增长
      • 政府措施和法规
    • 限制
      • 实施和整合成本高
      • 资料隐私和安全问题
    • 机会
      • 医疗保健 IT 和基础设施的投资不断增长。
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大、最畅销品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第五章：依类型

  • 解决方案
  • 服务

第六章：依互通性级别

  • 基础互通性
  • 结构互通性
  • 语意互通性

第七章：依部署方法

  • 基于云端
  • 本地部署

第 8 章：按应用

  • 诊断
  • 治疗
  • 其他的

第 9 章：按最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第十章：区域市场分析与成长机会

  • 北美洲
    • 关键区域特定动态
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 关键区域特定动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 拉丁美洲
    • 关键区域特定动态
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地区
  • 亚太
    • 关键区域特定动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 关键区域特定动态

第 11 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十二章：公司简介

  • Infor (Koch Industries Inc)
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 併购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT分析
  • Koninklijke Philips NV
  • Cerner Corporation (Oracle Health)
  • Orion Health Group Limited
  • NXGN Management, LLC (NextGen Healthcare)
  • OSP Labs
  • Epic Systems Corporation
  • ViSolve Inc
  • InterSystems Corporation
  • iNTERFACEWARE Inc

第十三章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 14 章：附录

简介目录
Product Code: HCIT9505

The global interoperable healthcare information technology (Health IT) Systems market reached US$ 3.08 billion in 2024 and is expected to reach US$ 23.18 billion by 2033, growing at a CAGR of 22.3% during the forecast period 2025-2033.

Interoperable Healthcare Information Technology (Health IT) Systems are digital platforms that facilitate the secure, seamless, and standardized exchange of healthcare data across various providers, institutions, and IT systems. These systems enable the effective collaboration of various technologies like EHRs, lab systems, imaging systems, and pharmacy systems. The primary goal of interoperability in healthcare is to improve patient care by providing accurate, up-to-date medical information. Interoperable systems support better coordination, reduce test duplication, enhance decision-making, and improve healthcare outcomes through efficient communication and collaboration across the healthcare ecosystem. Executive Summary

Market Dynamics: Drivers & Restraints

Rising Need for Seamless Patient Data Exchange

The interoperable healthcare IT systems market is driven by the need for seamless patient data exchange across healthcare settings, enabling faster and more coordinated care. These solutions improve clinical decision-making and reduce medical errors. Government mandates and incentives, particularly in developed markets like North America and Europe, support the push for connected health systems.

With the rising demand for these solutions, companies are launching advanced healthcare IT solutions. For instance, in March 2025, eHealth Technologies launched eHealth Connect on FHIR, a healthcare technology solution that integrates with leading EHR providers. This integration, based on the industry standard Fast Healthcare Interoperability Resources (FHIR), enables secure, real-time data exchange between health systems. The eHealth Connect platform provides a seamless connection for medical record retrieval between the two platforms.

High Implementation and Integration Costs

The high cost of implementing interoperable healthcare IT systems is a significant barrier for small and mid-sized healthcare providers, who face upfront investments for system upgrades, infrastructure changes, and staff training. The complexity of integrating legacy systems with modern platforms can also limit widespread adoption, especially in emerging markets.

Segment Analysis

The global interoperable healthcare information technology (Health IT) systems market is segmented based on type, level of interoperability, deployment method, application, end-user, and region.

Type:

The solutions from the type segment are expected to dominate the interoperable healthcare information technology (Health IT) systems market, with the highest market share

The interoperable healthcare IT systems market focuses on digital platforms, software, and tools that facilitate seamless data sharing and integration across various healthcare systems and providers. These solutions include electronic health record (EHR) interoperability systems, health information exchanges (HIEs), and enterprise data integration tools. The aim is to ensure secure and accurate medical information flow, improve patient outcomes, and reduce redundant procedures, supporting coordinated care.

The interoperable healthcare IT systems market is expanding due to global demand for connected systems, the adoption of interoperability solutions to reduce information silos, improve care transitions, and minimize clinical errors, government mandates and incentive programs in North America and Europe, and the rise in chronic disease prevalence, increasing healthcare data volumes, and the need for efficient medical data exchange in emergencies.

For instance, in February 2025, Edifecs, a global health information technology solutions company, launched its Healthcare Interoperability Cloud. This tool allows payers to strategically manage interoperability and compliance with CMS-9115-F and CMS-0057-F standards. Edifecs was identified as the leading partner for both FHIR and EDI solutions in a study of 99 payers. Since 1996, Edifecs has been instrumental in defining interoperability standards. These factors contribute to the growth of interoperable health IT solutions in the healthcare ecosystem.

Geographical Analysis

North America is expected to hold a significant position in the interoperable healthcare information technology (health IT) systems market with the highest market share

North America is experiencing significant growth in the interoperable healthcare IT systems market, driven by government initiatives, novel platform launches, advanced infrastructure, and high adoption of electronic health records. Regulations like the HITECH Act and the 21st Century Cures Act in the US encourage interoperable systems for secure data exchange. The region also benefits from investments in digital health, supportive reimbursement models, and value-based care. Major health IT companies and the widespread use of mobile health technologies contribute to the demand for interoperability solutions in healthcare settings.

For instance, in March 2025, CommonWell Health Alliance launched the CommonWell Marketplace, a platform aimed at enhancing interoperability and patient care by connecting healthcare providers with innovative solutions, enabling organizations to optimize their nationwide health data exchange priorities.

Competitive Landscape

The major global players in the interoperable healthcare information technology (Health IT) systems market include Infor (Koch Industries Inc), Koninklijke Philips N.V., Cerner Corporation (Oracle Health), Orion Health Group Limited, NXGN Management, LLC (NextGen Healthcare), OSP Labs, Epic Systems Corporation, ViSolve Inc, InterSystems Corporation, and iNTERFACEWARE Inc among others.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global interoperable healthcare information technology (Health It) systems market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Level of Interoperability
  • 2.5. Snippet by Deployment Method
  • 2.6. Snippet by Application
  • 2.7. Snippet by End User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Need for Seamless Patient Data Exchange
      • 3.1.1.2. Government Initiatives and Regulations
    • 3.1.2. Restraints
      • 3.1.2.1. High Implementation and Integration Costs
      • 3.1.2.2. Data Privacy and Safety Concerns
    • 3.1.3. Opportunity
      • 3.1.3.1. Growing Investment in Healthcare IT and Infrastructure.
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. Solutions*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Services

6. By Level of Interoperability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 6.1.2. Market Attractiveness Index, By Level of Interoperability
  • 6.2. Foundational Interoperability*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Structural Interoperability
  • 6.4. Semantic Interoperability

7. By Deployment Method

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 7.1.2. Market Attractiveness Index, By Deployment Method
  • 7.2. Cloud-Based*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. On-Premise

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Diagnosis*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Treatment
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. Latin America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of Latin America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Level of Interoperability
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Method
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Infor (Koch Industries Inc) *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals, etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Koninklijke Philips N.V.
  • 12.3. Cerner Corporation (Oracle Health)
  • 12.4. Orion Health Group Limited
  • 12.5. NXGN Management, LLC (NextGen Healthcare)
  • 12.6. OSP Labs
  • 12.7. Epic Systems Corporation
  • 12.8. ViSolve Inc
  • 12.9. InterSystems Corporation
  • 12.10. iNTERFACEWARE Inc

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us